USD 0.0
(25.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 1.11 Million USD | 2.83% |
2022 | 1.08 Million USD | 48.41% |
2021 | 731.21 Thousand USD | 80.77% |
2020 | 404.5 Thousand USD | -1.44% |
2019 | 410.41 Thousand USD | 15.94% |
2018 | 354 Thousand USD | -87.36% |
2017 | 2.8 Million USD | 4.3% |
2016 | 2.68 Million USD | 412.35% |
2015 | 524.08 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 1.19 Million USD | 3.74% |
2024 Q1 | 1.15 Million USD | 3.09% |
2023 FY | 1.11 Million USD | 2.83% |
2023 Q4 | 1.11 Million USD | -1.24% |
2023 Q1 | 1.09 Million USD | 0.9% |
2023 Q2 | 1.11 Million USD | 1.49% |
2023 Q3 | 1.12 Million USD | 1.68% |
2022 Q1 | 949.05 Thousand USD | 29.79% |
2022 FY | 1.08 Million USD | 48.41% |
2022 Q4 | 1.08 Million USD | 4.77% |
2022 Q2 | 1.02 Million USD | 8.09% |
2022 Q3 | 1.03 Million USD | 0.97% |
2021 Q2 | 648.54 Thousand USD | 39.04% |
2021 FY | 731.21 Thousand USD | 80.77% |
2021 Q1 | 466.43 Thousand USD | 0.0% |
2021 Q4 | 731.21 Thousand USD | 1.64% |
2021 Q3 | 719.42 Thousand USD | 10.93% |
2020 FY | 404.5 Thousand USD | -1.44% |
2019 FY | 410.41 Thousand USD | 15.94% |
2018 FY | 354 Thousand USD | -87.36% |
2017 FY | 2.8 Million USD | 4.3% |
2016 FY | 2.68 Million USD | 412.35% |
2015 FY | 524.08 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.2 Million USD | 49.415% |
Arrayit Corporation | 1.05 Million USD | -5.716% |
Atlantic International Corp. | 236.49 Thousand USD | -371.853% |
Biocept, Inc. | -788 Thousand USD | 241.613% |
Bioqual, Inc. | -12 Million USD | 109.294% |
CardioGenics Holdings Inc | 22.73 Thousand USD | -4807.489% |
DermTech, Inc. | 17.65 Million USD | 93.679% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 100.195% |
HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 115.127% |
IDenta Corp. | 524.85 Thousand USD | -112.615% |
Interpace Biosciences, Inc. | 7.69 Million USD | 85.496% |
Integrative Health Technologies, Inc. | -26.95 Thousand USD | 4240.375% |
InVitro International | -313.14 Thousand USD | 456.36% |
Lumos Diagnostics Holdings Limited | 1.56 Million USD | 28.737% |
Many Bright Ideas Technologies Inc. | -713.00 USD | 156609.677% |
Medical Imaging Corp. | 3.79 Million USD | 70.564% |
NovelStem International Corp. | 3.52 Million USD | 68.312% |
Optigenex Inc. | 8.93 Million USD | 87.509% |
PharmChem, Inc. | -1.49 Million USD | 174.672% |
Proteome Sciences plc | 14.57 Million USD | 92.343% |
Response Genetics, Inc | -13.08 Million USD | 108.528% |
Rennova Health, Inc. | 14.82 Million USD | 92.475% |
RushNet, Inc. | 4.8 Million USD | 76.756% |
ScreenPro Security Inc. | 135.58 Thousand USD | -723.012% |
Stella Diagnostics Inc. | 6.19 Million USD | 81.981% |
StageZero Life Sciences Ltd. | 1.78 Million USD | 37.463% |
Todos Medical Ltd. | 38.31 Million USD | 97.087% |